サマリー

神経変性疾患治療薬の世界市場 2022-2026 年
Technavioは神経変性疾患治療薬市場を監視しており、2022-2026年の間に197億4000万ドルの成長が見込まれ、予測期間中にCAGR7.98%で加速しています。当レポートでは、神経変性疾患治療薬市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境について最新の分析を提供しています。市場は、強力な医薬品開発パイプライン、神経変性疾患に関する高い研究資金、高感度な診断モダリティの利用可能性などによって牽引されています。
神経変性疾患治療薬市場の分析には、適応症セグメントと地理的展望が含まれます。
Technavioの神経変性疾患治療薬市場は、以下のようにセグメント化されています。
適応症別
- 多発性硬化症
- アルツハイマ-病
- パーキンソンズ病
- ハンチントン病
- その他
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における神経変性疾患治療薬市場の成長を牽引する主な要因の一つとして、高齢化社会の到来を挙げています。また、神経変性疾患の遺伝的基盤および分子病理学に対する理解の向上と高い経済的負担が、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。神経変性疾患治療薬市場に関する当レポートは、以下の分野を対象としています。
- 神経変性疾患治療薬市場のサイジング
- 神経変性疾患治療薬市場の予測
- 神経変性疾患治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AB Science SA、AbbVie Inc、Acadia Pharmaceuticals Inc、Biogen Inc、F. Hoffmann La Roche Ltd、H Lundbeck AS、三菱化学ホールディングス株式会社、ノバルティス AG、Sanofi、およびテバファーマスーティカルインダストリーズ Ltdなど、いくつかの主要神経変性疾患治療剤市場ベンダーに関する詳細分析を提供しています。また、神経変性疾患治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/neurodegenerative-diseases-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Indication
o 5.1 Market segments
o Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
o 5.2 Comparison by Indication
o Exhibit 26: Chart on Comparison by Indication
o Exhibit 27: Data Table on Comparison by Indication
o 5.3 Multiple sclerosis - Market size and forecast 2021-2026
o Exhibit 28: Chart on Multiple sclerosis - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Multiple sclerosis - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Multiple sclerosis - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Multiple sclerosis - Year-over-year growth 2021-2026 (%)
o 5.4 Alzheimers disease - Market size and forecast 2021-2026
o Exhibit 32: Chart on Alzheimers disease - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Alzheimers disease - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Alzheimers disease - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Alzheimers disease - Year-over-year growth 2021-2026 (%)
o 5.5 Parkinsons disease - Market size and forecast 2021-2026
o Exhibit 36: Chart on Parkinsons disease - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Parkinsons disease - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Parkinsons disease - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Parkinsons disease - Year-over-year growth 2021-2026 (%)
o 5.6 Huntingtons disease - Market size and forecast 2021-2026
o Exhibit 40: Chart on Huntingtons disease - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Huntingtons disease - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Huntingtons disease - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Huntingtons disease - Year-over-year growth 2021-2026 (%)
o 5.7 Others - Market size and forecast 2021-2026
o Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Indication
o Exhibit 48: Market opportunity by Indication ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 50: Chart on Market share by geography 2021-2026 (%)
o Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 52: Chart on Geographic comparison
o Exhibit 53: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 China - Market size and forecast 2021-2026
o Exhibit 90: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 91: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 92: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 93: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity by geography
o Exhibit 94: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 95: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 96: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 97: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 98: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 99: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 100: Matrix on vendor position and classification
o 10.3 AB Science SA
o Exhibit 101: AB Science SA - Overview
o Exhibit 102: AB Science SA - Product / Service
o Exhibit 103: AB Science SA - Key offerings
o 10.4 AbbVie Inc.
o Exhibit 104: AbbVie Inc. - Overview
o Exhibit 105: AbbVie Inc. - Product / Service
o Exhibit 106: AbbVie Inc. - Key offerings
o 10.5 Acadia Pharmaceuticals Inc.
o Exhibit 107: Acadia Pharmaceuticals Inc. - Overview
o Exhibit 108: Acadia Pharmaceuticals Inc. - Product / Service
o Exhibit 109: Acadia Pharmaceuticals Inc. - Key offerings
o 10.6 Biogen Inc.
o Exhibit 110: Biogen Inc. - Overview
o Exhibit 111: Biogen Inc. - Product / Service
o Exhibit 112: Biogen Inc. - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 113: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 114: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 115: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 116: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 117: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 H Lundbeck AS
o Exhibit 118: H Lundbeck AS - Overview
o Exhibit 119: H Lundbeck AS - Product / Service
o Exhibit 120: H Lundbeck AS - Key offerings
o 10.9 Mitsubishi Chemical Holdings Corp.
o Exhibit 121: Mitsubishi Chemical Holdings Corp. - Overview
o Exhibit 122: Mitsubishi Chemical Holdings Corp. - Business segments
o Exhibit 123: Mitsubishi Chemical Holdings Corp. - Key offerings
o Exhibit 124: Mitsubishi Chemical Holdings Corp. - Segment focus
o 10.10 Novartis AG
o Exhibit 125: Novartis AG - Overview
o Exhibit 126: Novartis AG - Business segments
o Exhibit 127: Novartis AG - Key offerings
o Exhibit 128: Novartis AG - Segment focus
o 10.11 Sanofi
o Exhibit 129: Sanofi - Overview
o Exhibit 130: Sanofi - Business segments
o Exhibit 131: Sanofi - Key news
o Exhibit 132: Sanofi - Key offerings
o Exhibit 133: Sanofi - Segment focus
o 10.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 134: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 135: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 136: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 137: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 138: Teva Pharmaceutical Industries Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 139: Inclusions checklist
o Exhibit 140: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 141: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 142: Research methodology
o Exhibit 143: Validation techniques employed for market sizing
o Exhibit 144: Information sources
o 11.5 List of abbreviations
o Exhibit 145: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Indication - Market share 2021-2026 (%)
Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Indication
Exhibits27: Data Table on Comparison by Indication
Exhibits28: Chart on Multiple sclerosis - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Multiple sclerosis - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Multiple sclerosis - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Multiple sclerosis - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Alzheimers disease - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Alzheimers disease - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Alzheimers disease - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Alzheimers disease - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Parkinsons disease - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Parkinsons disease - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Parkinsons disease - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Parkinsons disease - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Huntingtons disease - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Huntingtons disease - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Huntingtons disease - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Huntingtons disease - Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Indication ($ million)
Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits50: Chart on Market share by geography 2021-2026 (%)
Exhibits51: Data Table on Market share by geography 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits88: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits90: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits91: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits92: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits93: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits94: Market opportunity by geography ($ million)
Exhibits95: Impact of drivers and challenges in 2021 and 2026
Exhibits96: Overview on Criticality of inputs and Factors of differentiation
Exhibits97: Overview on factors of disruption
Exhibits98: Impact of key risks on business
Exhibits99: Vendors covered
Exhibits100: Matrix on vendor position and classification
Exhibits101: AB Science SA - Overview
Exhibits102: AB Science SA - Product / Service
Exhibits103: AB Science SA - Key offerings
Exhibits104: AbbVie Inc. - Overview
Exhibits105: AbbVie Inc. - Product / Service
Exhibits106: AbbVie Inc. - Key offerings
Exhibits107: Acadia Pharmaceuticals Inc. - Overview
Exhibits108: Acadia Pharmaceuticals Inc. - Product / Service
Exhibits109: Acadia Pharmaceuticals Inc. - Key offerings
Exhibits110: Biogen Inc. - Overview
Exhibits111: Biogen Inc. - Product / Service
Exhibits112: Biogen Inc. - Key offerings
Exhibits113: F. Hoffmann La Roche Ltd. - Overview
Exhibits114: F. Hoffmann La Roche Ltd. - Business segments
Exhibits115: F. Hoffmann La Roche Ltd. - Key news
Exhibits116: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits117: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits118: H Lundbeck AS - Overview
Exhibits119: H Lundbeck AS - Product / Service
Exhibits120: H Lundbeck AS - Key offerings
Exhibits121: Mitsubishi Chemical Holdings Corp. - Overview
Exhibits122: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibits123: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibits124: Mitsubishi Chemical Holdings Corp. - Segment focus
Exhibits125: Novartis AG - Overview
Exhibits126: Novartis AG - Business segments
Exhibits127: Novartis AG - Key offerings
Exhibits128: Novartis AG - Segment focus
Exhibits129: Sanofi - Overview
Exhibits130: Sanofi - Business segments
Exhibits131: Sanofi - Key news
Exhibits132: Sanofi - Key offerings
Exhibits133: Sanofi - Segment focus
Exhibits134: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits135: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits136: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits137: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits138: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits139: Inclusions checklist
Exhibits140: Exclusions checklist
Exhibits141: Currency conversion rates for US$
Exhibits142: Research methodology
Exhibits143: Validation techniques employed for market sizing
Exhibits144: Information sources
Exhibits145: List of abbreviations